Laurus Synthesis Private Limited

Form 483 issued December 12, 2023 · Anakapalli, India

Inspection
Dec 4 – Dec 12, 2023
Observations
1
Pages
5
FEI number
3010722058

In short: On December 12, 2023, FDA issued a Form 483 with 1 observation to Laurus Synthesis Private Limited in Anakapalli, India (FEI 3010722058) after an inspection that ran Dec 4 – Dec 12, 2023. The investigators were Joseph A. Piechocki and Rafeeq Habeeb. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Investigation of unexpected occurrences…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Laurus Synthesis Private Limited?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Laurus Synthesis Private Limited?

Joseph A. Piechocki and Rafeeq Habeeb are named on this Form 483, for the inspection of Dec 4 – Dec 12, 2023. Each investigator has a profile showing what they cite most.

When was Laurus Synthesis Private Limited inspected by FDA?

The inspection ran Dec 4 – Dec 12, 2023, and the Form 483 is dated December 12, 2023.

How do I get the full Form 483 for Laurus Synthesis Private Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free